| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Jazz Pharmaceuticals Plc (JAZZ) has 19 insiders with recent SEC Form 4 filings, including 0 buys and 16 sells. JAZZ is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 1.18M | $270.03M | - | |
| Dir | 390.7K | $89.18M | - | |
| CEO | 152.2K | $34.74M | - | |
| VP | 72.6K | $16.58M | - | |
| CFO | 59.6K | $13.61M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 11, 2017 | Riedel Norbert G63 | Director | Sell | 662 | $142.37 | $94,247.63 | -5.5% | |
| Aug 11, 2017 | McSharry Heather Ann61 | Director | Sell | 717 | $142.37 | $102,077.42 | -5.1% | |
| Aug 11, 2017 | Gray Peter63 | Director | Sell | 717 | $142.37 | $102,077.69 | -4.6% | |
| Aug 11, 2017 | Enright Patrick G74 | Director | Sell | 662 | $142.37 | $94,247.63 | -13.8% | |
| Aug 11, 2017 | Berns Paul L | Director | Sell | 662 | $142.37 | $94,247.63 | -5.3% | |
| Aug 11, 2017 | O'Keefe Kenneth W63 | Director | Sell | 662 | $142.37 | $94,247.58 | -2.5% | |
| Jul 20, 2017 | Hooper Suzanne Sawochka | EVP &General Counsel | Sell | 4,580 | $160.00 | $732,800.00 | -12.4% | |
| Jul 17, 2017 | Miller Michael Patrick46 | EVP, Us Commercial | Sell | 200 | $154.97 | $30,994.00 | -0.9% | |
| Jun 23, 2017 | Hooper Suzanne Sawochka | EVP &General Counsel | Sell | 420 | $160.00 | $67,200.00 | -1.1% | |
| Jun 15, 2017 | Miller Michael Patrick46 | EVP, Us Commercial | Sell | 200 | $150.65 | $30,130.00 | -0.9% |